NCT00140413View on ClinicalTrials.gov

Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Growth Hormone DeficiencySepto-Optic DysplasiaHypopituitarism

Interventions

DRUG

Nutropin AQ

Daily injection. Dosage dependent on weight.

Trial Locations (1)

90027

Childrens Hospital Los Angeles, Los Angeles

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Children's Hospital Los Angeles

OTHER